Genodermatoses and Cancer Susceptibility: Considerations for the Genetic Counselor with Katherine L. Nathanson, MD

This talk will review genodermatoses, in particularly those that also are associated with an increased risk of cancer. The skin findings in genodermatoses will be reviewed (with pictures).

We will discuss what questions to ask patients to elicit answers relevant to consider whether the patient has a genodermatoses. The medical management of patients with genodermatoses will be reviewed.

Only the live session qualifies for CEUs but when possible, we host the recordings on our website and NSGC recommends participants to use their personal email instead of work email addresses to ensure they receive their CEU certificates.

Ambry Genetics is approved as a provider for continuing education program by NSGC and ASCLS P.A.C.E ® Program.

Katherine L. Nathanson, MD | Presenter

Pearl Basser Professor of BRCA-related Research
Deputy Director, Abramson Cancer Center
University of Pennsylvania

Katherine (Kate) L. Nathanson, MD is a Professor of Medicine, in the Division of Translational Medicine and Human Genetics, and Genetics, at the Perelman School of Medicine of the University of Pennsylvania. She is Deputy Director of the Abramson Cancer Center, and Director of Genetics for the Basser Center for BRCA. Dr. Nathanson received her BA from Haverford College and MD from the University of Pennsylvania School of Medicine. She completed residencies in both Internal Medicine and Clinical Genetics, along with a post-doctoral fellowship in cancer genetics. She is an internationally recognized for both her clinical and research expertise in cancer genetics/genomics. Her research focuses on both inherited susceptibility to cancer and somatic genetic characterization of tumors, with interests across multiple tumor types, including testicular germ cell tumors, hereditary breast and ovarian cancers, melanoma and neuroendocrine tumors. Dr. Nathanson has published over 270 peer-reviewed articles in journals such as Nature, JAMA, New England Journal of Medicine and Cancer Cell. Dr. Nathanson has an extensive record of national service, serving on committees for multiple organizations, such as ACMG and AACR, several editorial boards, and scientific review committees including as Chair of the Cancer Genetics study section for the National Institutes of Health. She has been elected to the American Society of Clinical Investigation and the American Association of Physicians, and recently received the Osler Award for Patient Oriented Research at the University of Pennsylvania School of Medicine.

Jill S. Dolinsky, MS, CGC | Moderator

Director, Clinical Affairs, Ambry Genetics

Jill S. Dolinsky, MS, CGC is the Director of Clinical Affairs at Ambry Genetics. In this role, she drives efforts to enhance patient access to genetic testing by demonstrating the clinical utility of molecular genetic testing through data sharing, peer-review publication, and engagement with professional societies. Her current research interests include the clinical utility of multigene panel testing for hereditary cancer and cardiovascular diseases, the importance of broad data sharing in the interpretation of genomic data, increasing patient access to genetic counseling and testing through innovative service delivery models and the assessment of rare variants. Prior to joining Ambry in 2011, she worked in cardiovascular genetics at the University of Miami Miller School of Medicine, researching genetic etiologies of familial dilated cardiomyopathy along with practicing clinical cardiovascular genetics. In addition, she spent four years practicing cancer genetic counseling in the University of Pennsylvania Health System. She has more than 50 peer-reviewed publications in molecular genetics and has been an invited lecturer at numerous scientific meetings.